Stock List

Search by Ticker



Edwards Lifesciences Corporatio (NYSE:EW)
Stock Analysis

▲ 1.16%0.88

Stock Analysis

The following stock analysis is based on 6.9 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.

Stock Exchange

Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.


It is in the healthcare sector.

Current Status of Edwards Lifesciences Corporatio

It is currently trading at $76.66 ($75.78 the previous day).


The next reporting date is in 76 days (2020 10 27).

CNN estimates profits for the upcoming quarter will be $0.43 per share ($1.1B). The current Canada / US exchange rate is 1.33134.

Over the past 12 months, $0 worth of shares have been purchased and $71006046 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 26.0% per year assuming steady exponential growth. The actual 5 year average is 28.32. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year73.836367187530.9+ Above Average
2 year56.42762096774232.4+ Above Average
3 year42.61171548117222.8- Below Average
4 year34.70289795918416.3- Below Average
5 year29.83022727272739.2+ Above Average
Edwards Lifesciences Corporatio is projected by analysts to get to $88.00 within the next 12 months (14.8%), but preticted targets range from as high as $95.00 (23.9%) and as low as $52(-32.2%).


The worst drop it has had in recent years is -36.2%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.

Stock shape test


With an average increase of 26.0% year over year, if Edwards Lifesciences Corporatio is bought at the worst time, Stockmarketizer analysts estimate it will take 16.7 months before the stock will recover to the original purchase price. The P/E value is 65.13. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.


Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.

The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.

Tradingview BuySell Widget

Yahoo News Feed

Long-Term Leaders List Welcomes This Giant Software Company

Fri, 07 Aug 2020 19:03:48 IBDand's Long-Term Leaders continue to power higher as the raging bull market hits new highs. Long-Term Leader Portfolio Welcomes Led by founder Marc Benioff, (CRM) remains the dominant player in customer relationship management software. Since going ...... Read Full Article

TMO vs. EW: Which Stock Is the Better Value Option?

Thu, 06 Aug 2020 15:40:03 TMO vs. EW: Which Stock Is the Better Value Option?... Read Full Article

Vanguard Health Care Fund Adds 3 Stocks to Portfolio

Fri, 31 Jul 2020 16:58:36 Fund focused on health reveals 2nd-quarter trades Continue reading...... Read Full Article

The Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund

Mon, 27 Jul 2020 19:18:39 Health care-focused fund releases 2nd-quarter portfolio Continue reading...... Read Full Article

Edwards Inches Closer To Breakout On $100 Million Heart-Valve Beat

Fri, 24 Jul 2020 20:24:14 Edwards Lifesciences handily topped Wall Streetand's second-quarter expectations amid a resurgence in heart-valve replacements. EW stock inched slightly closer to a buy point Friday.... Read Full Article

P/E Ratio Insights for Edwards Lifesciences

Fri, 24 Jul 2020 13:48:00 In the current session, Edwards Lifesciences Inc. (NYSE: EW) is trading at $77.38, after a 0.05% rise. Over the past month, the stock increased by 20.14%, and in the past year, by 11.87%. With performance like this, long-term shareholders optimistic but others are more ...... Read Full Article

Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View

Fri, 24 Jul 2020 13:22:01 Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.... Read Full Article

Edwards Lifesciences Blows Past Q2 Earnings Estimates

Fri, 24 Jul 2020 10:03:00 Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thursday, and the stock jumped 5% in after-hours trading.... Read Full Article

Edwards Lifesciences Corp (EW) Q2 2020 Earnings Call Transcript

Fri, 24 Jul 2020 02:31:19 With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer and Scott Ullem Chief Financial Officer. Just after the close of regular trading, Edwards Lifesciences released second quarter 2020 financial results.... Read Full Article

Edwards Lifesciences (EW) Q2 Earnings and Revenues Beat Estimates

Thu, 23 Jul 2020 21:35:09 Edwards Lifesciences (EW) delivered earnings and revenue surprises of 126.67% and 18.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

Edwards Lifesciences: Q2 Earnings Insights

Thu, 23 Jul 2020 20:49:37 Shares of Edwards Lifesciences (NYSE:EW) moved higher by 3.5% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 75.36% year over year to $0.34, which beat the estimate of $0.17.Revenue of $925,000,000 declined by 14.90% year over year, ...... Read Full Article

Edwards Lifesciences Stares Down A Buy Point After Its Earnings Beat

Thu, 23 Jul 2020 20:37:53 Late Thursday, Edwards Lifesciences reported adjusted income of 34 cents per share on $925 million in sales for its second quarter ended June 30. In response, EW stock popped.... Read Full Article

Edwards Lifesciences Reports Second Quarter Results

Thu, 23 Jul 2020 20:15:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2020.... Read Full Article

If You Own Edwards Lifesciences (EW) Stock, Should You Sell It Now?

Wed, 22 Jul 2020 17:04:41 Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Large-Cap Growth Fund posted a return of 27.86% for the quarter, outperforming its benchmark, the Russell 1000 Growth Index which returned 27.84% in the same quarter. ...... Read Full Article

Why Earnings Season Could Be Great for Edwards Lifesciences (EW)

Wed, 22 Jul 2020 12:39:12 Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.... Read Full Article

Is Edwards Lifesciences Corporationand's(NYSE:EW) Recent Stock Performance Tethered To Its Strong Fundamentals?

Mon, 20 Jul 2020 16:36:39 Most readers would already be aware that Edwards Lifesciencesand' (NYSE:EW) stock increased significantly by 9.3% over...... Read Full Article

Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for

Thu, 16 Jul 2020 16:31:04 Edwards Lifesciences (EW) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

Whatand's in Store for Edwards Lifesciences (EW) in Q2 Earnings?

Thu, 16 Jul 2020 13:36:01 Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciencesand' (EW) Q2 revenues.... Read Full Article

Paul LaViolette Appointed To Edwards Lifesciences Board Of Directors

Wed, 15 Jul 2020 12:30:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directors. LaViolette has 40 years of experience in global ...... Read Full Article

Edwardsand' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries

Wed, 15 Jul 2020 12:30:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received approval from the U.S. Food and Drug Administration (FDA) for the KONECT RESILIA aortic valved conduit (...... Read Full Article